Ribotix/ Ribolib

About this medicine

Originator: KISQALI by NOVARTIS · Manufacturer: Beacon pharma. Indication & Dosage: Ribotix/ Ribolib (Ribociclib succinate), generic KISQALI is a prescription medicine used to treat patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer. Ribociclib succinate is in a class of medicine called kinase inhibitors. Ribociclib succinate works by blocking the action of an abnormal protein that signals cancer cells to multiply. Ribociclib succinate helps slow or stop the spread of Cancer cells. Ribotix/ Ribolib manufactured by Beacon Pharma Ltd. In Bangladesh. Ribociclib succinate has to take orally once daily for 21 days with Or Without food, then stopping the medicine for 7 days. Side Effects: The most common side effects of Ribociclib succinate are: Tiredness , diarrhea , headache , back pain, nausea , vomiting , or loss of appetite. The above information comes from the Internet. Please consult with doctor for medical advice.

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.